Abstract:CXC chemokine receptor 6 (CXCR6), a seven-transmembrane domain G-protein-coupled receptor, plays a pivotal regulatory role in inflammation and tissue damage through its interaction with CXC chemokine ligand 16 (CXCL16). This axis is implicated in the pathogenesis of various fibrotic diseases and correlates with clinical parameters that indicate disease severity, activity, and prognosis in organ fibrosis, including afflictions of the liver, kidney, lung, cardiovascular system, skin, and intestines. Soluble CXCL16 (sCXCL16) serves as a chemokine, facilitating the migration and recruitment of CXCR6-expressing cells, while membrane-bound CXCL16 (mCXCL16) functions as a transmembrane protein with adhesion properties, facilitating intercellular interactions by binding to CXCR6. The CXCR6/CXCL16 axis is established to regulate the cycle of damage and repair during chronic inflammation, either through modulating immune cell-mediated intercellular communication or by independently influencing fibroblast homing, proliferation, and activation, with each pathway potentially culminating in the onset and progression of fibrotic diseases. However, clinically exploiting the targeting of the CXCR6/CXCL16 axis requires further elucidation of the intricate chemokine interactions within fibrosis pathogenesis. This review explores the biology of CXCR6/CXCL16, its multifaceted effects contributing to fibrosis in various organs, and the prospective clinical implications of these insights.

CXCL6: A potential therapeutic target for inflammation and cancer

Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer

The CXCL8-CXCR1/2 pathways in cancer

CXCL3: A key player in tumor microenvironment and inflammatory diseases

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

Clinical Significance of CXCL13/CXCR5 Axis in Human Cancers

CXCL13-CXCR5 axis：regulation in inflammatory diseases and cancer

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy

The CCL20-CCR6 Axis in Cancer Progression

CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer

The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease

CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target

CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer

Regulative Role of the CXCL13-CXCR5 Axis in the Tumor Microenvironment

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

CXCL13-CXCR5 Axis: Regulation in Inflammatory Diseases and Cancer.